Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
Nucleo Research is building an AI-first medtech platform that analyzes oncology CT scans to generate structured outputs for researchers and clinicians. The team values ownership, rapid learning, and collaboration across time zones, with on-site integrations as needed.
Ideal candidates bring hands-on coding in Python or TypeScript, experience owning products end-to-end (including regulatory considerations), and strong interaction with AI coding tools.
Nucleo Research builds AI technology for oncology, turning routine medical imaging into quantitative insights for researchers, hospitals and pharma teams across cancer care and research. Nucleo’s goal is to develop the technologies that will enable the next generation of patient care and clinical trials.
Our founders are former researchers at Apple and Stanford. Healthcare data is messy and complex, but it holds real patterns that the right data and models can uncover. That’s the problem we started Nucleo to solve, and it’s what makes the work here both hard and worth it.
We are looking for exceptional candidates to join our technical team and build our platform engineering. They will help shape how an AI-first company works. The ideal candidate uses AI coding tools every day, takes full ownership of what they build, and will be central to how we scale. We value fast learners over years of experience. Strong candidates have owned products end to end across several layers of the stack (commercial work, side projects and open source all count) and are exceptional at working with AI coding tools: judging their output against a high bar, catching their errors, and giving feedback that cuts down on future corrections. A smaller part of the role is supporting and onboarding our users. They are comfortable collaborating across time zones and traveling for on-site integrations.
Nucleo is an AI-first medtech startup building the first agentic platform for oncology CT scans.
Our mission is simple and ambitious: reduce the time from cancer diagnosis to treatment by automating the most time-consuming, manual steps in the clinical workflow.
Today, hospitals still rely on radiologists and oncologists to manually extract critical information from CT scans, for example body composition, sarcopenia, tumor measurements, RECIST classification. This is slow, expensive, and error-prone. We replace these steps with AI systems that read CT scans end-to-end and generate structured, clinically useful outputs in seconds.
We work with top-tier hospitals in the US and Europe and are building toward FDA-cleared clinical software used directly in real oncology workflows.
We operate in a high-ownership, early-stage environment focused on shipping reliable AI into real clinical practice.